Nanosystems in drug targeting: Opportunities and challenges

被引:251
作者
Vasir, JK
Reddy, MK
Labhasetwar, VD
机构
[1] Univ Nebraska, Med Ctr, Coll Pharm, Dept Pharmaceut Sci, Omaha, NE 68198 USA
[2] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA
关键词
nanoparticles; nanosystems; targeting; ligands; drug and gene therapy;
D O I
10.2174/1573413052953110
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The long cherished goal of targeting drugs to specific sites in the body, where the pharmacological action is desired and sparing other tissues has been actively pursued all these years. The concept of 'magic bullets' given by Ehrlich has now seen a metamorphosis to 'magic wands', in the form of targeted drug delivery systems. The magic, all due to the specific targeting ligands which guide the drug carriers to the molecular targets be it on cell surface or nuclear membranes. Nanosystems including the nano-sized (<1000 nm) drug carrier systems, such as polymeric nanoparticles, liposomes, micelles and polymer-drug conjugates are the vanguards of this ever-evolving field. Targeting drugs to specific sites, and maintaining pharmacologically relevant drug levels at the site for a period required for desired therapeutic action is what makes the nanosystems - the burgeoning magic wands. Substantial challenges still exist in terms of biological barriers. Nevertheless, the approaches like directly reaching the target using catheters, or using exogenous guiding mechanisms (magnetic fields and ultrasound), and exploiting the accessible targets on vascular endothelium are emerging as new and promising trends. It is conceivable, that despite all the formidable challenges, interplay of different disciplines ranging from engineering to biology will make the dream of drug targeting come true!
引用
收藏
页码:47 / 64
页数:18
相关论文
共 108 条
[1]   Transporting therapeutics across the blood-brain barrier [J].
Abbott, NJ ;
Romero, IA .
MOLECULAR MEDICINE TODAY, 1996, 2 (03) :106-113
[2]   Magnetic drug targeting - Biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment [J].
Alexiou, C ;
Jurgons, R ;
Schmid, RJ ;
Bergemann, C ;
Henke, J ;
Erhardt, W ;
Huenges, E ;
Parak, F .
JOURNAL OF DRUG TARGETING, 2003, 11 (03) :139-149
[3]   Drug delivery systems: Entering the mainstream [J].
Allen, TM ;
Cullis, PR .
SCIENCE, 2004, 303 (5665) :1818-1822
[4]   LDL induced association of anionic liposomes with cells and delivery of contents as shown by the increase in potency of liposome dependent drugs [J].
Amin, K ;
Ng, KY ;
Brown, CS ;
Bruno, MS ;
Heath, TD .
PHARMACEUTICAL RESEARCH, 2001, 18 (07) :914-921
[5]   Increased receptor-mediated gene delivery to the liver by protamine-enhanced-asialofetuin-lipoplexes [J].
Arangoa, MA ;
Düzgünes, N ;
de Ilarduya, CT .
GENE THERAPY, 2003, 10 (01) :5-14
[6]  
Banks WA, 1998, J NEUROSCI RES, V54, P522, DOI 10.1002/(SICI)1097-4547(19981115)54:4<522::AID-JNR9>3.0.CO
[7]  
2-O
[8]   BODY DISTRIBUTION OF FULLY BIODEGRADABLE [C-14] POLY(LACTIC ACID) NANOPARTICLES COATED WITH ALBUMIN AFTER PARENTERAL ADMINISTRATION TO RATS [J].
BAZILE, DV ;
ROPERT, C ;
HUVE, P ;
VERRECCHIA, T ;
MARLARD, M ;
FRYDMAN, A ;
VEILLARD, M ;
SPENLEHAUER, G .
BIOMATERIALS, 1992, 13 (15) :1093-1102
[9]   Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitro [J].
Bender, AR ;
vonBriesen, H ;
Kreuter, J ;
Duncan, IB ;
RubsamenWaigmann, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (06) :1467-1471
[10]   ENHANCED CYTOTOXICITY OF DOXORUBICIN ENCAPSULATED IN POLYISOHEXYLCYANOACRYLATE NANOSPHERES AGAINST MULTIDRUG-RESISTANT TUMOR-CELLS IN CULTURE [J].
BENNIS, S ;
CHAPEY, C ;
COUVREUR, P ;
ROBERT, J .
EUROPEAN JOURNAL OF CANCER, 1994, 30A (01) :89-93